Motivational interviewing for thalassemia treatment adherence
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests whether motivational interviewing, a type of counseling, helps people with thalassemia take their medications more regularly and feel more confident in managing their health. If you are an adult with thalassemia who needs regular blood transfusions and takes iron chelation therapy, this trial might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have beta-thalassemia major and need regular blood transfusions.
- You have been taking iron chelation therapy for at least 6 months.
- You can attend counseling sessions and fill out questionnaires.
- You can speak and understand Arabic or English.
- You are not currently hospitalized for a serious medical problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two common antioxidants—N-acetyl cysteine and alpha lipoic acid—can help people with beta thalassemia. It aims to see if these supplements improve health outcomes when added to usual care.
This study checks how well children with beta thalassemia stick to their daily oral chelation pill (deferasirox). It aims to find ways to help them take it more regularly, improving iron control and reducing complications.
This trial tests a one-time gene therapy using your own stem cells to help you produce healthy red blood cells and reduce or eliminate the need for regular blood transfusions. It is for people with transfusion-dependent beta-thalassemia who are between 3 and 35 years old.
This trial tests a one-time gene therapy using your own blood stem cells to treat severe beta-thalassemia. It may help you stop needing regular blood transfusions.
This trial studies an investigational medicine in adults with beta thalassemia intermedia (including non-transfusion dependent thalassemia). The goal is to see how well the treatment works and how safe it is for people whose hemoglobin runs in a certain range.
This study tests a special system (Hemanext One) that stores red blood cells with less oxygen, to see if it helps people with thalassemia who need regular transfusions. It may reduce side effects or improve how well the transfusions work.
Hear when a new Thalassemia Majors (Beta-Thalassemia Major) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.